Ekf Diagnostics Holding PLC (LON:EKF) shares crossed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $32.58 and traded as high as $33.72. Ekf Diagnostics shares last traded at $33.50, with a volume of 143,000 shares traded.
The firm has a market cap of $152.12 million and a PE ratio of 14.57. The stock has a 50 day simple moving average of GBX 33.16 and a two-hundred day simple moving average of GBX 32.57. The company has a debt-to-equity ratio of 2.67, a quick ratio of 1.34 and a current ratio of 1.81.
Ekf Diagnostics Company Profile (LON:EKF)
EKF Diagnostics Holdings plc designs, develops, manufactures, and sells diagnostic instruments, reagents, and other ancillary products in the Americas, Europe, the Middle East, Africa, and internationally. It offers DiaSpect Tm, an hemoglobin analyzer; DiaSpect Hemoglobin T Low to determine low levels of hemoglobin in plasma and serum specimens, aqueous solutions, or stored or banked erythrocytes; Hemo Control, a point-of-care hemoglobin analyzer that provides quantitative and lab quality hemoglobin results; and HemataStat II, a centrifuge that provides a hematocrit reading for six blood samples.
See Also: Stock Symbol
Receive News & Ratings for Ekf Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ekf Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.